KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Non-Current Deffered Revenue (2017 - 2025)

Historic Non-Current Deffered Revenue for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to $157.0 million.

  • Moderna's Non-Current Deffered Revenue rose 6526.32% to $157.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.0 million, marking a year-over-year increase of 6526.32%. This contributed to the annual value of $58.0 million for FY2024, which is 3012.05% down from last year.
  • Moderna's Non-Current Deffered Revenue amounted to $157.0 million in Q3 2025, which was up 6526.32% from $65.0 million recorded in Q2 2025.
  • Over the past 5 years, Moderna's Non-Current Deffered Revenue peaked at $692.0 million during Q2 2023, and registered a low of $58.0 million during Q1 2024.
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $175.0 million (2021), whereas its average is $283.4 million.
  • As far as peak fluctuations go, Moderna's Non-Current Deffered Revenue surged by 24745.76% in 2021, and later tumbled by 9138.19% in 2024.
  • Over the past 5 years, Moderna's Non-Current Deffered Revenue (Quarter) stood at $615.0 million in 2021, then grew by 9.43% to $673.0 million in 2022, then crashed by 87.67% to $83.0 million in 2023, then tumbled by 30.12% to $58.0 million in 2024, then surged by 170.69% to $157.0 million in 2025.
  • Its last three reported values are $157.0 million in Q3 2025, $65.0 million for Q2 2025, and $58.0 million during Q1 2025.